Pfizer Animal Health announced that EXCEDE (ceftiofur crystalline free acid) Sterile Suspension is now approved by the Food and Drug Administration (FDA) for the treatment of acute postpartum metritis in just two doses. This new approval for EXCEDE represents a major step forward in modernizing metritis treatment options. For the industry to continue to improve the rate of meat drug residues found pre-slaughter in cull dairy cows, there is a need for on-label solutions that effectively treat metritis while also offering the assurance of residue risk avoidance.
In recognition of that fact, EXCEDE continues to be backed Pfizer Animal Health's Residue Free Guarantee.
“The two-dose regimen of EXCEDE is an efficacious and cost-effective metritis treatment option with zero milk discard,” says Doug Hammon, senior manager, cattle technical services, Pfizer Animal Health.
“I believe veterinarians and producers will find the two-dose regimen for EXCEDE to be a more convenient alternative to daily metritis treatments.” PD
—From Pfizer Animal Health news release
